Sign in

CIK 0001628171 · Large accelerated filer

Revolution Medicines, Inc.

Sign in to watch
Ticker
RVMD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
472029180
Phone
650-481-6801
Business address
700 SAGINAW DR, REDWOOD CITY, CA, 94063

Securities

  • RVMD Common Stock Nasdaq
  • RVMDW Warrant Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$85,328,124
in 21 filings, $85.3M under 10b5-1 plans

Net −$85,328,124. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. GOLDSMITH MARK A −$20.8M See Remarks sold 28% of stake
  2. Kelsey Stephen Michael −$19.8M See Remarks sold 26% of stake
  3. Kim Lorence H. −$15.0M Director sold 100% of stake
  4. Cislini Jeff −$12.7M SVP & General Counsel sold 54% of stake
  5. Anders Jack −$7.5M Chief Financial Officer sold 25% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-06-26 Clyburn Frank Director Grant or award · Stock Option (Right to Buy) +10,337 10,337
2025-06-20 Cislini Jeff General Counsel Sale 10b5-1 −1,912 $39.61 $76K 54,093
2025-06-16 Horn Margaret A Chief Operating Officer Sale 10b5-1 −3,575 $156.12 $558K 154,647
2025-06-16 Horn Margaret A Chief Operating Officer Sale 10b5-1 −3,510 $39.83 $140K 150,675
2025-06-16 GOLDSMITH MARK A See Remarks Sale 10b5-1 −13,496 $39.83 $538K 428,720
2025-06-16 Cislini Jeff General Counsel Sale 10b5-1 −1,878 $39.83 $75K 56,005
2025-06-16 Anders Jack Chief Financial Officer Sale 10b5-1 −2,170 $39.83 $86K 113,314
2025-06-16 Kelsey Stephen Michael See Remarks Sale 10b5-1 −4,289 $39.83 $171K 289,414
2025-06-16 Wei Lin Chief Medical Officer Sale 10b5-1 −2,173 $39.83 $87K 90,499
2025-03-20 Cislini Jeff General Counsel Sale 10b5-1 −2,041 $38.71 $79K 57,723
2025-03-17 Cislini Jeff General Counsel Sale 10b5-1 −1,458 $39.04 $57K 59,764
2024-08-05 Clyburn Frank Director Grant or award · Stock Option (Right to Buy) +26,540 26,540

Page 18 of 18 · 352 trades